BeiGene Ltd ADR Stock
BeiGene Ltd ADR Stock
A very strong showing by BeiGene Ltd ADR today, with an increase of €5.00 (3.450%) compared to yesterday's price.
We see a rather positive sentiment for BeiGene Ltd ADR with 8 Buy predictions and 1 Sell predictions.
With a target price of 255 € there is a hugely positive potential of 68.87% for BeiGene Ltd ADR compared to the current price of 151.0 €.
So far the community has only identified positive things for BeiGene Ltd ADR stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of BeiGene Ltd ADR in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of BeiGene Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| BeiGene Ltd ADR | 3.450% | 16.154% | 5.594% | -34.914% | -8.485% | -48.639% | - |
| Ardelyx Inc. | 22.800% | 7.123% | -7.526% | 58.693% | 9.273% | 3.541% | - |
| Salarius Pharmaceuticals Inc. | 11.650% | -5.069% | 5.641% | -71.389% | -25.766% | -98.474% | -99.994% |
| Brainstorm Cell | -0.540% | -26.131% | -44.654% | -86.685% | 58.405% | -87.328% | - |
Comments
BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at TD Cowen from $235.00 to $236.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BGNE provided by MarketBeat
BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at JPMorgan Chase & Co. from $184.00 to $186.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BGNE provided by MarketBeat
BeiGene, Ltd. (NASDAQ: BGNE) had its price target lowered by analysts at Guggenheim from $350.00 to $345.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BGNE provided by MarketBeat